Article

Steve Melnick, Answers How ACOs Will Impact the Pharmacy Benefit and Medical Costs

Steve Melnick, President, SM Innovations, says that accountable care organizations (ACOs) will impact the pharmacy benefit by moving the healthcare system from a volume-based to a value-based model.

Steve Melnick, President, SM Innovations, says that accountable care organizations (ACOs) will impact the pharmacy benefit by moving the healthcare system from a volume-based to a value-based model. By moving to a value-based model, pharmacies will need to build long-term relations with patients and understand how the whole population is managing. Mr Melnick notes that it might be too early to tell if ACOs will impact cost and quality, but there will continue to be funding for experimentation and development.

"Ultimately what we'd like to see are models that improve cost, improve quality, and improve patient satisfaction," said Melnick.

Related Videos
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
Pierluigi Porcu, MD
Benjamin Chen, MD, PhD
Kimberly Westrich, MA, chief strategy officer, NPC
Image credit: Medical technology and futuristic concept. Doctor hologram modern virtual screen interface | SOMKID - stock.adobe.com
Erin Weber, MS
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Marla Black Morgan, MD, Phoebe Neurology Associates
Elizabeth Grush, MBA
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo